{{Rsnum
|rsid=9455973
|Chromosome=6
|position=168182326
|Orientation=plus
|GMAF=0.2612
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 18.9 | 81.1
| HCB | 10.2 | 46.0 | 43.8
| JPT | 8.8 | 48.7 | 42.5
| YRI | 32.0 | 47.6 | 20.4
| ASW | 15.8 | 57.9 | 26.3
| CHB | 10.2 | 46.0 | 43.8
| CHD | 9.3 | 41.1 | 49.5
| GIH | 5.0 | 31.7 | 63.4
| LWK | 20.9 | 55.5 | 23.6
| MEX | 5.3 | 28.1 | 66.7
| MKK | 14.1 | 49.4 | 36.5
| TSI | 1.0 | 18.8 | 80.2
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs9455973
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363821
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9455973
|overall_frequency_n=41
|overall_frequency_d=128
|overall_frequency=0.320312
|n_genomes=30
|n_genomes_annotated=0
|n_haplomes=39
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}